Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

2.55
Delayed Data
As of Sep 22
 +0.08 / +3.24%
Today’s Change
1.02
Today|||52-Week Range
2.63
+66.67%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close2.47
Today’s open2.45
Day’s range2.43 - 2.57
Volume957,711
Average volume (3 months)812,354
Market cap$290.5M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-31.48%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book19.76

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...+0.06+1.57%
OBSVObseva SA+0.10+1.32%
NLNKNewLink Genetics Cor...+0.18+1.67%
MNOVMediciNova Inc+0.30+5.10%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts